Veterinary good pharmacovigilance practices (VGVP)
Veterinary good pharmacovigilance practices (VGVP) are a set of measures to facilitate pharmacovigilance for veterinary medicines in the European Union (EU) / European Economic Area (EEA). They apply to marketing-authorisation holders, the European Medicines Agency (EMA) and medicines regulatory authorities in EU Member States.
They cover veterinary medicines authorised centrally via the Agency as well as medicines authorised at national level.
As of 28 January 2022, the VGVP guideline superseded previous EU guidance on pharmacovigilance for veterinary medicines.
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
